Matrix Surgical Holdings, LLC. dba Matrix Surgical USA

Matrix Surgical USA designs, manufactures, and distributes OMNIPORE® porous high-density polyethylene implants for craniofacial reconstructive and aesthetic surgery. The company specializes in both standard surgical implants and customized patient-specific implants using advanced computer imaging and 3D modeling technologies. Product lines include facial augmentation implants (chin, malar, rim, midface, mandibular), neurosurgical implants for cranial and skull-based reconstruction, reconstructive shapes for traumatic defects and microtic ear reconstruction, orbital trauma correction implants (sheets, wedges, blocks), and spheres for enucleation and evisceration procedures. OMNIPORE implants have received FDA 510(k) clearance, CE marking in Europe, and regulatory approvals from ANVISA (Brazil), KFDA (South Korea), TFDA (Taiwan), TGA (Australia), and other stringent regulatory authorities. Manufacturing is performed in the USA to meet quality and reliability standards. The company serves plastic surgeons, otolaryngologists, neurosurgeons, and oral maxillofacial surgeons globally. Matrix Surgical USA operates with a subsidiary presence in Brazil as of 2024, expanding its international distribution and market reach in Latin America.